We provide you with 20 years of free, institutional-grade data for NMTR stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of NMTR. Explore the full financial landscape of NMTR stock.
| Reported Date | CIK | Ticker | Type |
|---|
9 Meters Biopharma, Inc(NASDAQ:NMTR) 
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on patients with rare and unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS) and celiac disease, as well as for undisclosed rare diseases and/or unmet needs. The company i...
Website: http://www.innovatebiopharma.com/
Founded: 2012
CEO: Sandeep Laumas
Sector: Manufacturing
Industry: Computer Storage Device Manufacturing
Share this website to your friends
The information provided in this report about NMTR stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.